BAY73-4506
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BAY73-4506, covering 2012-11-28 to 2015-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma [Phase 2]